Novomax Pharma Private Limited
About Novomax Pharma Private Limited
Data last updated:
Novomax Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2012PTC238218. Its GSTIN is 07AAECN1699K1ZZ (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Lakhvinder Singh Arora and Harpreet Singh Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 4 Induastiral Area Phase – I Mayapuri, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2024, the company reported a revenue of ₹51.88 Lakh, a growth of 90% compared to the previous year. For the same year it recorded a net profit of ₹15.97 Lakh (net margin 30.8%) and EBITDA of ₹19.92 Lakh (EBITDA margin 38.4%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Novomax Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 4 Induastiral Area Phase – I Mayapuri, New Delhi, Delhi, India – 110064
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Novomax Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novomax Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novomax Pharma Private Limited, buy the company report.
Financials of Novomax Pharma Private Limited
FY 2025 filings availableNovomax Pharma Private Limited reported revenue of ₹51.88 Lakh (up 90% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 90% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 361% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 38.4% | ||||
| Net Profit Margin | 30.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novomax Pharma Private Limited, buy the company report.
Board of directors of Novomax Pharma Private Limited
Novomax Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakhvinder Singh Arora Also directs: Novopharm Life Sciences Private Limited, M H Medicus Private Limited, Mex Pharma Private Limited and 1 more | Director | 01 Jun 2014 | 12 Years 4 Months | Current |
| Harpreet Singh Arora Also directs: Novopharm Life Sciences Private Limited, M H Medicus Private Limited, Panchdeep Medi-Care Private Limited. and 1 more | Director | 28 Jun 2012 | 14 Years 3 Months | Current |
| Rajan Chatterjee Also directs: M H Medicus Private Limited | Director | 01 Jun 2014 | 12 Years 4 Months | Current |
| Rajeev Anand Also directs: Novopharm Life Sciences Private Limited | Director | 28 Jun 2012 | 14 Years 3 Months | Current |
Peer comparison
Novomax Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hawksbill Pharmaceuticals Private Limited | ₹52.1 Lakh (FY 2025) | 9.0% | Ahmedabad, Gujarat, India | |||
| Prochem Bioceuticals Private Limited | ₹52.07 Lakh (FY 2025) | -13.0% | Delhi, India | |||
| Myriad Pharmaceuticals Private Limited | ₹52.03 Lakh (FY 2025) | 10.0% | Nagpur, Maharashtra, India | |||
| Bioziv Healthcare Private Limited | ₹51.99 Lakh (FY 2024) | -23.0% | Manimajra, Chandigarh, India | |||
| Novomax Pharma Private Limitedthis company | ₹51.88 Lakh (FY 2024) | ₹15.97 Lakh | 30.8% | 90.0% | New Delhi, Delhi, India | |
| Stemgrow Pharmaceuticals Private Limited | ₹51.86 Lakh (FY 2024) | 300.0% | Hyderabad, Telangana, India | |||
| Axxontis Biopharmaceuticals Private Limited | ₹51.65 Lakh (FY 2024) | -1.0% | Hoshiarpur, Punjab, India | |||
| Suraj Remedies Private Limited | ₹51.48 Lakh (FY 2025) | -54.0% | Uttar Pradesh, India |
To see the full peer comparison of Novomax Pharma Private Limited, buy the company report.
Auditor
Novomax Pharma Private Limited is audited by ASHOK SHARMA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHOK SHARMA & ASSOCIATES | FY 2020 | 004161N |
Shareholding
The shareholding of Novomax Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Novomax Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Novomax Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novomax Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novomax Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECN1699K1ZZ | Delhi | Active | 01 Jul 2017 |
| 08AAECN1699K1ZX | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Novomax Pharma Private Limited, buy the company report.
Recent activity
Novomax Pharma Private Limited has 5 board changes on record since 2012: 4 appointments and 1 cessation. The latest: Lakhvinder Singh Arora was appointed as Director on 01 Jun 2014.
Frequently asked questions
Novomax Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 June 2012 (14+ years old) and is registered under CIN U24232DL2012PTC238218.
Novomax Pharma has 4 current directors:
- Lakhvinder Singh Arora - Director
- Harpreet Singh Arora - Director
- Rajan Chatterjee - Director
- Rajeev Anand - Director
The latest financial statements of Novomax Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Novomax Pharma is 07AAECN1699K1ZZ, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAECN1699K1ZX (Rajasthan).
The CIN (Corporate Identification Number) of Novomax Pharma is U24232DL2012PTC238218. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novomax Pharma was incorporated on 28 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Novomax Pharma by revenue are Hawksbill Pharmaceuticals Private Limited, Prochem Bioceuticals Private Limited, Myriad Pharmaceuticals Private Limited, Bioziv Healthcare Private Limited, Stemgrow Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Lakhvinder Singh Arora was appointed as Director on 01 Jun 2014. Lalit Kumar Goel ceased to be Director on 01 Jun 2014. Rajan Chatterjee was appointed as Director on 01 Jun 2014. Novomax Pharma has 5 board changes on record in total.
The registered office of Novomax Pharma is at A – 4 Induastiral Area Phase – I Mayapuri, New Delhi, Delhi, India – 110064.
Novomax Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Novomax Pharma is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.